I. Achour
AuthID: R-00K-GKV
1
TITLE: MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naive (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial
AUTHORS: Ahn, M J.; Kim, S W.; Carcereny Costa, E.; Rodriguez, L. M.; Oliveira, J.; Insa Molla, M. A.; Majem, M.; Costa, L.; Su, W C.; Lee, K. H.; Yang, J. C H.; Spigel, D. R.; Cho, E. K.; D'Arcangelo, M.; Garcia Campelo, M. R.; Delmonte, A.; Mitchell, P.; Achour, I.; Subramaniam, D.; Felip, E.;
PUBLISHED: 2022, SOURCE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, ISSUE: 7
AUTHORS: Ahn, M J.; Kim, S W.; Carcereny Costa, E.; Rodriguez, L. M.; Oliveira, J.; Insa Molla, M. A.; Majem, M.; Costa, L.; Su, W C.; Lee, K. H.; Yang, J. C H.; Spigel, D. R.; Cho, E. K.; D'Arcangelo, M.; Garcia Campelo, M. R.; Delmonte, A.; Mitchell, P.; Achour, I.; Subramaniam, D.; Felip, E.;
PUBLISHED: 2022, SOURCE: Annual Meeting of the European-Society-for-Medical-Oncology (ESMO) in ANNALS OF ONCOLOGY, VOLUME: 33, ISSUE: 7
INDEXED IN: 
WOS
WOS